Literature DB >> 21251894

CD40 is overexpressed by HPV16/18-E6 positive cervical carcinoma and correlated with clinical parameters and vascular density.

Qin Huang1, Qiu-Xia Qu, Fang Xie, Ting Zhang, Jian-Ming Hu, You-Guo Chen, Xue-Guang Zhang.   

Abstract

CD40 is expressed in many tumor cells, however, its role in tumor biology is yet to be demonstrated. In the present study, we investigated the role of CD40 in cervical carcinoma. In vivo, we evaluated CD40 expression in 56 cervical carcinoma tissues, 43 cervicitis and 38 normal cervix, and investigated the relationship between CD40 and HPV antigen, histopathological parameters, vascular density, and vascular endothelial growth factor (VEGF) expressions. The results clearly demonstrated that CD40 expression, including membranous and cytoplasmic staining, was significantly higher in cervical carcinoma than in the cervicitis and normal cervix. The expression of CD40 was significantly correlated with HPV and VEGF expressions and microvessel density (MVD). These observations provide evidence that CD40 may be involved in neovascularization of cervical carcinoma, they also suggest that CD40 and VEGF may be useful biomarkers for evaluating the risk of developing cervical carcinoma, and may also be used as a target for therapy.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251894     DOI: 10.1016/j.canep.2010.12.004

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  7 in total

Review 1.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

2.  Manipulated microenvironment in human papilloma virus-infected epithelial cells: is the CD40-CD154 pathway beneficial for host or virus?

Authors:  Takatoshi Shimauchi; Vincent Piguet
Journal:  J Invest Dermatol       Date:  2014-12       Impact factor: 8.551

3.  Cervical cancer-associated promoter polymorphism affects akna expression levels.

Authors:  G A Martínez-Nava; K Torres-Poveda; A Lagunas-Martínez; M Bahena-Román; M A Zurita-Díaz; E Ortíz-Flores; A García-Carrancá; V Madrid-Marina; A I Burguete-García
Journal:  Genes Immun       Date:  2014-11-06       Impact factor: 2.676

Review 4.  Exploring the therapeutic rationale for angiogenesis blockade in cervical cancer.

Authors:  Lauren S Krill; Krishnansu S Tewari
Journal:  Clin Ther       Date:  2015-01-01       Impact factor: 3.393

Review 5.  Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.

Authors:  Jill K Alldredge; Krishnansu S Tewari
Journal:  Oncologist       Date:  2016-03-29

6.  Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment.

Authors:  Paweł Łaniewski; Haiyan Cui; Denise J Roe; Dana M Chase; Melissa M Herbst-Kralovetz
Journal:  NPJ Precis Oncol       Date:  2020-08-03

7.  Immune Response of Plasmacytoid Dendritic Cells Stimulated by Human Papillomavirus (HPV) E6 in an In Vitro System.

Authors:  Xiaoxian Xu; Shuhui Yuan; Xiaojing Zhang; Hanmei Lou
Journal:  Med Sci Monit       Date:  2020-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.